Deep Learning Guided Optimization of Translation Efficiency for mRNA Vaccine Development
- Delivered mRNA vaccines benefit from a high protein yield to stimulate an effective immune response
- Training RiboNN, a deep learning model, to predict translation efficiency — a major determinant of protein yield — among numerous cell types
- RiboNN can be used to guide the design of translation-optimized mRNA therapeutics